Female Reproductive Physiology — MCQs
A middle-aged female presents with increasing visual loss, breast enlargement, and irregular menses. What is the most appropriate investigation to diagnose the underlying condition?
Which of the following enzymes is not required for the formation of estradiol?
Which of the following statements about the postmenopausal state is false?
In the transition from a Graafian follicle to a functional corpus luteum, which of the following cellular events occurs?
Which of the following statements about the anatomy of the Fallopian tubes is true?
What is the recommended daily calcium intake for adult non-pregnant females?
Pseudotumor cerebri is seen in -
What does the Gross Reproduction Rate (GRR) measure?
Which of the following structures has the function of capacitation?
Which occupational exposure may cause sterility in females ?
Female Reproductive Physiology Indian Medical PG Practice Questions and MCQs
Question 1: A middle-aged female presents with increasing visual loss, breast enlargement, and irregular menses. What is the most appropriate investigation to diagnose the underlying condition?
- A. S. calcitonin
- B. S. prolactin (Correct Answer)
- C. S. hemoglobin concentration
- D. S. calcium
Explanation: ***S. prolactin*** - **Hyperprolactinemia** is the most likely cause of the presented symptoms: **galactorrhea** (**breast enlargement** with milk production), **amenorrhea** (**irregular menses**), and **visual field defects** due to a pituitary tumor compressing the optic chiasm [1]. - Measuring serum prolactin levels directly confirms or rules out **hyperprolactinemia**, guiding further management, including imaging of the pituitary gland if elevated [1]. *S. calcitonin* - **Calcitonin** is a hormone primarily involved in **calcium regulation** and is typically elevated in medullary thyroid carcinoma. - The presented symptoms (visual loss, breast enlargement, irregular menses) are not characteristic of elevated calcitonin levels or a **medullary thyroid carcinoma**. *S. hemoglobin concentration* - **Hemoglobin concentration** measures the amount of oxygen-carrying protein in red blood cells and is used to diagnose **anemia** or polycythemia. - While general labs might include this, it is not directly relevant to the specific constellation of symptoms pointing towards an **endocrine or pituitary issue**. *S. calcium* - **Serum calcium** levels are checked for disorders of calcium metabolism, such as **hyperparathyroidism** or hypocalcemia. - Though calcium is regulated by hormones, the symptoms of **visual loss**, **breast enlargement**, and **menstrual irregularities** are not typically associated with primary disturbances in calcium levels.
Question 2: Which of the following enzymes is not required for the formation of estradiol?
- A. Aromatase
- B. 3β-hydroxysteroid dehydrogenase
- C. 11β-hydroxylase (Correct Answer)
- D. 17α-hydroxylase
Explanation: ***11β-hydroxylase*** - This enzyme is crucial for the **synthesis of cortisol** and **aldosterone** within the adrenal cortex, converting 11-deoxycortisol to cortisol and 11-deoxycorticosterone to corticosterone. - It plays no direct role in the synthesis pathway of **estrogen**, specifically estradiol, which is synthesized from androgens. *3β-hydroxysteroid dehydrogenase* - This enzyme is required for multiple steps in steroidogenesis, including the conversion of **pregnenolone to progesterone** and **DHEA to androstenedione**, both of which are precursors to estrogens like estradiol. - Its activity is essential for moving from **Δ5 steroids** to **Δ4 steroids**, an early and critical step in androgen and subsequent estrogen synthesis. *Aromatase* - **Aromatase (CYP19A1)** is the enzyme directly responsible for converting androgens (**androstenedione and testosterone**) into estrogens (**estrone and estradiol**, respectively). - It catalyzes the **aromatization of the A-ring** of the steroid structure, a defining step in estrogen synthesis. *17α-hydroxylase* - This enzyme (CYP17A1) is involved in crucial steps leading up to estrogen synthesis, including the conversion of **progesterone to 17α-hydroxyprogesterone** and **pregnenolone to 17α-hydroxypregnenolone**. - Its activity is necessary for the formation of **androgens** (like DHEA and androstenedione), which are direct precursors for estrogen synthesis.
Question 3: Which of the following statements about the postmenopausal state is false?
- A. High FSH
- B. Low LH (Correct Answer)
- C. Low estrogen
- D. High androgen
Explanation: ***Low LH*** - This statement is **FALSE** because **LH (luteinizing hormone) levels are markedly elevated** in postmenopausal women. - The drop in ovarian estrogen production removes the **negative feedback** on the pituitary, leading to **increased LH and FSH secretion**. - Both gonadotropins (LH and FSH) are characteristically **high in postmenopause**. *High FSH* - This statement is true; **FSH (follicle-stimulating hormone) levels are markedly elevated** in postmenopausal women. - The elevated FSH is a direct consequence of the **lack of negative feedback** from inhibin and estrogen produced by the ovaries. *Low estrogen* - This statement is true; **estrogen levels plummet significantly** after menopause due to the **cessation of ovarian follicular activity**. - This **estrogen deficiency** is responsible for many postmenopausal symptoms, such as hot flashes, vaginal atrophy, and bone loss. *High androgen* - While androgens are still produced by the adrenal glands and ovaries postmenopause, their **absolute levels also decline with age**. - The statement is somewhat ambiguous, but androgens do **not increase** in absolute terms; rather, the **estrogen-to-androgen ratio changes** because estrogen falls more dramatically.
Question 4: In the transition from a Graafian follicle to a functional corpus luteum, which of the following cellular events occurs?
- A. Granulosa cells begin to express estrogen receptors
- B. Granulosa cells begin to express LH receptors (Correct Answer)
- C. Theca cells begin to express androgen receptors
- D. Granulosa cells begin to express progesterone receptors
Explanation: ***Granulosa cells begin to express LH receptors*** - During the late follicular phase, under **FSH** stimulation, **granulosa cells** in the developing Graafian follicle acquire **LH receptors**. - This acquisition of LH receptors is essential for the transition to a corpus luteum, as it enables the **LH surge** to trigger ovulation and subsequently stimulate **luteinization** and **progesterone production** by the corpus luteum. - While the initial expression occurs before ovulation, the functional significance becomes apparent during the transformation to the corpus luteum, making this the most critical receptor-related event in this transition among the given options. *Granulosa cells begin to express estrogen receptors* - Granulosa cells already express **estrogen receptors** in early follicular stages, which are essential for their proliferation and **aromatase synthesis**. - Estrogen receptor expression is characteristic of developing follicles throughout folliculogenesis, not specifically associated with corpus luteum formation. *Theca cells begin to express androgen receptors* - **Theca cells** produce **androgen precursors** (androstenedione, testosterone) under LH stimulation during the follicular phase, which granulosa cells convert to estrogen. - While theca cells contribute to the corpus luteum (theca-lutein cells), androgen receptor expression is not the primary defining cellular event of this transition. *Granulosa cells begin to express progesterone receptors* - The corpus luteum is the major source of **progesterone** in the luteal phase, but granulosa cells do not significantly upregulate progesterone receptors as part of their luteinization. - The key functional change is the cells' ability to *produce* large amounts of progesterone in response to LH, not increased progesterone receptor expression.
Question 5: Which of the following statements about the anatomy of the Fallopian tubes is true?
- A. Length is 20 cm
- B. All of the options
- C. Medial to lateral structures are isthmus, interstitial part, ampulla & fimbriae
- D. Lateral to medial structures are fimbriae, ampulla, isthmus, interstitial part (Correct Answer)
Explanation: ***Lateral to medial structures are fimbriae, ampulla, isthmus, interstitial part*** - The Fallopian tube segments, from the **ovary** towards the **uterus**, logically follow this order to facilitate **egg transport**. - The **fimbriae** capture the egg, the **ampulla** is the site of fertilization, the **isthmus** is a narrow segment, and the **interstitial part** traverses the uterine wall [1]. *Length is 20 cm* - The typical length of the **Fallopian tube** is approximately **10-12 cm**, not 20 cm [1]. - A length of 20 cm would be significantly longer than the average human Fallopian tube. *Medial to lateral structures are isthmus, interstitial part, ampulla & fimbriae* - This order is incorrect as it describes the segments from the **uterus** towards the **ovary** but places the **isthmus** before the **interstitial part**. - The correct order from medial to lateral (uterus to ovary) would be **interstitial part**, **isthmus**, **ampulla**, and **infundibulum/fimbriae** [1]. *All of the options* - Since two of the other options contain factual inaccuracies regarding the length and the medial-to-lateral structural arrangement, this option cannot be correct. - Only one statement can be entirely true when specifically asked for the "true" statement among given choices.
Question 6: What is the recommended daily calcium intake for adult non-pregnant females?
- A. 1000 mg (Correct Answer)
- B. 1200 mg
- C. 600 mg
- D. 800 mg
Explanation: ***1000 mg*** - The recommended daily calcium intake for adult non-pregnant females (ages 19-50) is **1000 mg** according to **WHO and international guidelines** (US RDA/NIH) to maintain bone health and prevent osteoporosis. - This is the **standard recommendation** used in most medical textbooks and international nutritional guidelines. - Adequate calcium intake supports various bodily functions, including **nerve transmission**, **muscle contraction**, and **hormone secretion**. *1200 mg* - While 1200 mg is the recommended intake for **older women (above 50-70 years)** or during **pregnancy/lactation** per some guidelines, it is generally higher than necessary for non-pregnant adult females aged 19-50. - While not harmful, this higher dose is not specifically indicated for the general non-pregnant adult female population. *600 mg* - This amount of calcium is **lower than the internationally recommended daily allowance** for adult women (though it aligns with some regional guidelines like ICMR for sedentary women). - For optimal bone health and prevention of osteoporosis, **1000 mg is the widely accepted standard** in medical education. *800 mg* - This value is **below the internationally recommended daily intake** for adult non-pregnant females, which could lead to long-term calcium deficiency. - Insufficient calcium intake can increase the risk of conditions like **osteopenia** and **osteoporosis**.
Question 7: Pseudotumor cerebri is seen in -
- A. Obese women in the age group 20-40 yrs. (Correct Answer)
- B. Obese males 20-40 yrs.
- C. Thin males 50-60 yrs.
- D. Thin females 50-60 yrs.
Explanation: ***Obese women in the age group 20-40 yrs.*** - **Pseudotumor cerebri** (also known as idiopathic intracranial hypertension) is most commonly seen in **obese women** of childbearing age, typically between **20 and 40 years old** [1]. - Risk factors include **obesity** and certain medications like **tetracyclines**, **excess vitamin A**, or **oral contraceptives** [1]. *Obese males 20-40 yrs.* - While obesity is a risk factor, **males** are significantly less commonly affected by pseudotumor cerebri than females [1]. - The disease has a strong predilection for the female gender in this age group. *Thin males 50-60 yrs.* - **Pseudotumor cerebri** is rarely observed in individuals who are **thin** and in older age groups like **50-60 years old**. - This demographic does not align with the typical patient profile for this condition. *Thin females 50-60 yrs.* - Similar to thin males, **thin females** in the **50-60 year age group** are not typically affected by pseudotumor cerebri. - The condition primarily impacts young to middle-aged obese women.
Question 8: What does the Gross Reproduction Rate (GRR) measure?
- A. Number of female children a woman would have during her reproductive years, assuming no mortality (Correct Answer)
- B. Number of total children a woman would have during her reproductive years (both male and female), assuming no mortality
- C. Number of live births per 1000 women in a given year
- D. Number of male children a woman would have during her reproductive years, assuming no mortality
Explanation: ***Number of female children a woman would have during her reproductive years, assuming no mortality*** - The **Gross Reproduction Rate (GRR)** specifically measures the average number of **daughters** a woman is expected to have over her lifetime. - It assumes no mortality among women through their reproductive years, indicating the potential for a new generation of mothers. *Number of total children a woman would have during her years of reproduction (both male and female), at the current age-specific fertility rates, assuming no mortality* - This definition describes the **Total Fertility Rate (TFR)**, which includes all live births (male and female) per woman. - While both GRR and TFR assume no mortality, the GRR is explicitly focused on the female offspring. *Number of live births per 1000 women in a given year* - This statement defines the **General Fertility Rate (GFR)**, which is a cross-sectional measure for a specific year. - GRR is a longitudinal measure that considers a woman's entire reproductive lifespan. *Number of male children a woman would have during her reproductive years, assuming no mortality* - The GRR is specifically interested in the **female offspring** as they are the ones who can potentially reproduce and replace the current generation of mothers. - Male offspring are not directly counted in the GRR calculation.
Question 9: Which of the following structures has the function of capacitation?
- A. Male reproductive tract
- B. Vas deferens
- C. Female reproductive tract (Correct Answer)
- D. Capillary
Explanation: ***Female reproductive tract*** - **Capacitation** is a biochemical process that occurs in the **female reproductive tract** (primarily the fallopian tubes and uterus), enabling sperm to gain the ability to fertilize an egg. - This process involves the removal of **cholesterol and glycoproteins** from the sperm head membrane, which modifies its motility and prepares it for the **acrosome reaction**. - Capacitation typically takes **5-6 hours** and is essential for successful fertilization. *Male reproductive tract* - The male reproductive tract produces and stores sperm, but it is **not the site where capacitation occurs**. - Sperm are immature and unable to fertilize an egg when they leave the male reproductive tract. - Sperm only gain fertilizing capacity after exposure to the female reproductive tract environment. *Vas deferens* - The vas deferens is a tube that transports sperm from the epididymis to the ejaculatory duct. - It is a part of the male reproductive tract and does **not contribute to capacitation**. *Capillary* - Capillaries are tiny blood vessels involved in nutrient and waste exchange, entirely unrelated to sperm function or capacitation. - This option is biologically implausible in the context of reproduction.
Question 10: Which occupational exposure may cause sterility in females ?
- A. Lead
- B. Carbon monoxide
- C. Mercury
- D. Agricultural insecticides (Correct Answer)
Explanation: ***Agricultural insecticides*** - Exposure to **organochlorine** and **organophosphate** insecticides can have significant **reproductive toxicity** in females, leading to **infertility** or **sterility**. - These chemicals can disrupt **hormonal balance**, interfere with **ovarian function**, cause **menstrual irregularities**, and lead to **developmental toxicity** in offspring. - Well-documented occupational hazard in agricultural workers with chronic exposure. *Lead* - Lead is a well-established **reproductive toxicant** affecting **both males and females**. - In females, lead causes **menstrual irregularities**, **ovarian dysfunction**, **reduced fertility**, **spontaneous abortions**, and can contribute to sterility. - It disrupts the **hypothalamic-pituitary-ovarian axis** and has direct **gonadotoxic effects**. - While agricultural insecticides are more specifically associated with female sterility in occupational contexts, lead is also a significant reproductive hazard. *Carbon monoxide* - Carbon monoxide poisoning primarily causes **hypoxia** by binding to hemoglobin, forming **carboxyhemoglobin**. - It does not directly cause **sterility** in females; its main reproductive concern relates to **fetal hypoxia** and adverse pregnancy outcomes during exposure. *Mercury* - Mercury exposure, particularly **methylmercury**, is a known **neurotoxin** and can cause **developmental abnormalities**. - While it can affect pregnancy outcomes and cause **menstrual disorders** at high exposures, it is not typically cited as a primary occupational cause of **female sterility** compared to agricultural insecticides.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free